VIVUS, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 87   

Articles published

VVUS 5.36 +0.11 (2.10%)
price chart
Hot Biotech Stocks: Galena Biopharma (GALE), Ariad Pharmaceuticals (ARIA ...
VIVUS, Inc. (NASDAQ:VVUS) today announced that J. Martin Carroll, Mark B. Logan and Robert N. Wilson have decided not to stand for re-election when their terms expire at the Annual Meeting of Stockholders, to be held on June 20, 2014.
Related articles »  
Stocks Buzz � Arch Coal Inc (NYSE:ACI), VIVUS, Inc. (NASDAQ:VVUS ...
VIVUS, Inc. (NASDAQ:VVUS), is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health.
Related articles »  
5 Activist-Owned Stocks Analysts Think Will Triple [Cliffs Natural Resources ...
3) Vivus (NASDAQ:VVUS) is owned by activist First Manhattan. The stock has a current share price of $4.84. Analysts are targeting as much as $18.
Stock's Trend Analysis Report -Alexion Pharmaceuticals, (ALXN), Tenet ...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) increased 0.50% and closed at $149.80 on a traded volume of 2.30 million shares, in comparison to 2.13 million shares of average trading volume.
Investor's Alert on: Cell Therapeutics Inc (NASDAQ:CTIC), VIVUS, Inc. (VVUS ...
Las Vegas, NV - April 15, 2014 - (TechSonian) �Cell Therapeutics Inc (NASDAQ:CTIC) a biopharmaceutical company, is involved in the acquisition, development, and commercialization of treatments for cancer.
Related articles »  
Active Movers - Arch Coal Inc (NYSE:ACI), VIVUS, Inc. (NASDAQ:VVUS ...
Arch Coal Inc (NYSE:ACI) ended higher 0.83% and complete the day at $4.88. The total number of shares changed hands during the day was 6.51 million.
Biotech New Highs: VIVUS, Inc. (NASDAQ:VVUS), PharmAthene (NYSEMKT:PIP ...
VIVUS, Inc. (NASDAQ:VVUS) has been on a steady slide over the past five trading days - thanks to a quick rejection from its 40-day moving average one week ago.
Related articles »  
Top Gainers Biotech- Zalicus Inc (NASDAQ:ZLCS), VIVUS, Inc. (NASDAQ:VVUS ...
Zalicus Inc. (ZLCS), as well as Epirus Biopharmaceuticals, Inc. (Epirus), released that they have entered into a definitive contract under which Epirus will merge with a wholly-owned subsidiary of Zalicus in an all-stock transaction.
Trending Stocks - VIVUS, Inc. (NASDAQ:VVUS), CareFusion Corporation (NYSE ...
Las Vegas, NV - 14 April 2014 - (Tech Sonian) - A biopharmaceutical company VIVUS, Inc. (NASDAQ:VVUS) commercializing Qsymia capsules CIV for the treatment of obesity, provided a business update and reported its financial results for the 4th quarter ...
Active Mover On News- Kinder Morgan Energy Partners (NYSE:KMP), VIVUS Inc ...  eMarketsDaily
Related articles »  
Investors Alert: Cell Therapeutics Inc (NASDAQ:CTIC), VIVUS, Inc. (NASDAQ ...
New York, NY - (MARKET NEWS CALL) - 4/14/2014� Mast Therapeutics Inc (NYSEMKT:MSTX)'s shares dropped 11.36% to $0.55.
Related articles »